Patent - Abbreviated New Drug Application Cases
Cases 41 - 50 of 2,103
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. DEVA HOLDING A.S.
as 2:2024cv04404
Plaintiff: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., NORTON (WATERFORD) LTD. and TEVA PHARMACEUTICALS USA, INC.
Defendant: DEVA HOLDING A.S. (a/k/a DEVA HOLDINGS A.S.)
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Bayer HealthCare LLC et al v. Aurobindo Pharma Ltd. et al
as 1:2024cv00399
Plaintiff: Bayer HealthCare LLC and Meda Pharmaceuticals Inc.
Defendant: Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Teva Pharmaceuticals International GmbH et al v. BendaRx USA Corp
as 1:2024cv00395
Plaintiff: Teva Pharmaceuticals International GmbH, Cephalon, LLC and Eagle Pharmaceuticals Inc.
Defendant: BendaRx USA Corp
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Azurity Pharmaceuticals, Inc. et al v. Hetero Labs Limited et al
as 1:2024cv00396
Plaintiff: Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited
Defendant: Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Doe v. The Individuals, Corporations, Limited Liability Companies, Partnerships, and Unincorporated Associations Identified on Schedule A To The Complaint
as 1:2024cv02535
Plaintiff: John Doe
Defendant: The Individuals, Corporations, Limited Liability Companies, Partnerships, and Unincorporated Associations Identified on Schedule A To The Complaint
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Doe v. The Individuals, Corporations, Limited Liability Companies, Partnerships, and Unincorporated Associations Identified on Schedule A to the Complaint
as 1:2024cv02537
Plaintiff: John Doe
Defendant: The Individuals, Corporations, Limited Liability Companies, Partnerships, and Unincorporated Associations Identified on Schedule A to the Complaint
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Doe v. The Unincorporated Association Identified on the Schedule A to the Complaint
as 1:2024cv02539
Plaintiff: John Doe
Defendant: The Unincorporated Association Identified on the Schedule A to the Complaint
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. SANDOZ INC.
as 3:2024cv04327
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: SANDOZ INC.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. ALKEM LABORATORIES LTD.
as 3:2024cv04312
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: ALKEM LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. HETERO USA, INC. et al
as 3:2024cv04317
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: HETERO USA, INC., HETERO LABS LTD. UNIT-V and HETERO LABS LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?